• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What are Clinical Trials?
    • Become a Clinical Trial Volunteer
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » EU Lays Out Work Plan for Improving Clinical Research in the Trade Bloc

EU Lays Out Work Plan for Improving Clinical Research in the Trade Bloc

September 12, 2022

The European Medicines Agency, the European Commission and the Heads of Medicines Agencies have published a list of priorities for their ACT EU program, which launched at the beginning of the year with a goal of enhancing the EU’s clinical trial capabilities.

The multi-year work plan for the Accelerating Clinical Trials in the EU (ACT EU) initiative lays out ten priority actions, as well as deliverables and proposed timing for each, that are meant to spur growth in clinical trial innovation, stakeholder engagement and regulatory collaborations within the trade bloc as it seeks to become more competitive as a destination for clinical research.

“The aim is to further develop the EU as a focal point for clinical research, promote the development of high-quality, safe and effective medicines, and to better integrate clinical research in the European health system,” the EMA said. “ACT EU will strengthen the European environment for clinical trials, whilst maintaining the high level of protection of trial participants, data robustness and transparency that EU citizens expect.”

For example, under the first priority action, “mapping and governance,” the EU will map out existing initiatives within its regulatory network in order to develop a strategy that coordinates the work done by different clinical trial expert groups across its complex regulatory landscape. This process is anticipated to be carried out in Q4 2022.

The work plan also includes the task of modernizing GCP, specifically by implementing ICH E6(R3). To this end, the EU plans to hold a multi-stakeholder workshop in the first quarter of 2023, followed by making changes in EU guidances in the third quarter and developing a communications and change management strategy in the fourth.

In addition, the EU intends to ramp up its efforts on clinical trial training by creating an “educational ecosystem” with help from universities and subject matter experts. This will ultimately deliver a comprehensive set of training modules on drug development and regulatory science and is set to begin in Q4 2022. These efforts are expected to take one year, approximately, according to the work plan.

The trade bloc also plans to address the rising use of complex trial designs, such as basket trials and master protocols, and will publish guidance on decentralized trials (DCT) by year’s end.

Read the full work plan here: https://bit.ly/3KV98C3.

 

To view more CenterWatch Weekly stories, click here.

    Upcoming Events

    • 14Apr

      MAGI 2024: The Clinical Research Conference

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Jonathan Seltzer

      Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials

    • Quality_Compass-360x240.png

      Ask the Experts: Applying Quality by Design to Protocols

    • Obesity Treatment Patient

      Clinical Trials Need Greater Representation of Obese Patients, Experts Say

    • Modernize-360x240.png

      FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing